Hear our immuno-oncology expert describe how to improve your odds transitioning from in vitro to in vivo and ultimately to the clinic. Download Poster
Publication Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD) Learn More
Publication Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis Learn More
